🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an investigator-initiated study of safety, efficacy and tolerabilit...
Status
Completed
Location
Deaconess Clinic Gateway Health Center
Start Date
2009-07
Trial ID
NCT00939120
Treatments Being Tested
The purpose of the study is to assess the impact of treatment with tolterod...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-03
Trial ID
NCT00143481
Treatments Being Tested
The primary purpose of the trial is to show that tolterodine ER has no effe...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-12
Trial ID
NCT00411437
Treatments Being Tested
This study will investigate the safety and efficacy of Sanctura XR (trospiu...
Status
Completed
Location
Multiple Locations
Start Date
2010-03
Trial ID
NCT01089751
Treatments Being Tested
An 8-week randomized, controlled, pilot clinical trial of Mirabegron compar...
Status
Completed
Location
University of California, San Francisco
Start Date
2016-02
Trial ID
NCT02436889
Treatments Being Tested
This study is being done to compare frequency of urination during the night...
Status
Terminated
Location
Massachusetts General Hospital
Start Date
2006-04
Trial ID
NCT00323635
Treatments Being Tested
The purpose of this study is to determine whether combination therapy with ...
Status
Completed
Location
University of Wisconsin
Start Date
2012-11
Trial ID
NCT01741454
Treatments Being Tested
A study to identify factors that are associated with improved effectiveness...
Status
Completed
Location
Site US1051
Start Date
2015-01-05
Trial ID
NCT02386072
Treatments Being Tested
This study is randomized controlled trial in which urgency incontinent wome...
Status
Completed
Location
University of New Mexico Health Science Center
Start Date
2013-04-22
Trial ID
NCT01829425
Treatments Being Tested
This study will evaluate the pharmacologic effects of exposure to darifenac...
Status
Completed
Location
Investigative Site
Start Date
2008-05
Trial ID
NCT00703703
Treatments Being Tested